New
simple-to-install, universal connectors for asceptic parenteral manufacturing
are making it much easier for pharmaceutical manufacturers to combine
single-use technologies with permanent, stainless-steel systems and/or with
other single-use systems from different manufacturers with different coupling
requirements.
This type of
connector makes it possible to shrink the footprint of manufacturing operations
in the clean room and reduce the steps necessary for achieving sterile
manufacturing. Both advantages add up to improved efficiency and productivity.
However,
there are even greater potential benefits if this type of technology can be
shown to provide an asceptic connection outside of the clean room.
Do you think
connector technology can achieve such a level of sterility assurance? What type
of evidence would you need to be convinced? Would you then feel comfortable
using them outside of the clean room in order to leverage the numerous
efficiency, productivity, and cost gains such an approach would make possible?
If you
haven’t signed up to receive it yet, take the opportunity right now. Just click
here. Also check out the Pharmaceutical Technology/Biopharm International
Marketplace at www.pharmabiomarketplace.com.
Cynthia Challener, PhD
Editor
The Pharmaceutical
Sciences, Manufacturing & Marketplace Report
We noticed that your article (http://psmmr.blogspot.fr/2013/06/out-of-box-thinking.html) is related to life sciences and mentioned on Biowebspin, the Bio Dashboard for the largest network in Biotech, Pharma & Medtech. Here is the link: http://www.biowebspin.com/members/cvuarchey/activity/122359/
ReplyDeleteYou can also post your article abstracts on Biowebspin Public Place (http://www.biowebspin.com/activity/) and be seen by thousands of life science visitors all across the globe.
Many Regards,
The Biowebspin’s team